Fig. 7From: Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expressionA working model of the role of cholesterol/EGFR/Src/Erk/SP1/ERRα axis in dictating the response of NSCLC cells to EGFR-TKIs and potential for cholesterol-lowing drugs or ERRα inverse agonist to counteract EGFR-TKIs resistance in NSCLCBack to article page